Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Chronic Disease Management Market, by Type
1.4.2 LAMEA Chronic Disease Management Market, by End User
1.4.3 LAMEA Chronic Disease Management Market, by Disease Type
1.4.4 LAMEA Chronic Disease Management Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2019, Sep – 2022, May) Leading Players
Chapter 4. LAMEA Chronic Disease Management Market by Type
4.1 LAMEA Solutions Market by Country
4.2 LAMEA Services Market by Country
Chapter 5. LAMEA Chronic Disease Management Market by End User
5.1 LAMEA Healthcare Providers Market by Country
5.2 LAMEA Healthcare Payers Market by Country
5.3 LAMEA Others Market by Country
Chapter 6. LAMEA Chronic Disease Management Market by Disease Type
6.1 LAMEA Diabetes Market by Country
6.2 LAMEA Cardiovascular diseases Market by Country
6.3 LAMEA Asthma Market by Country
6.4 LAMEA Chronic obstructive pulmonary disorders Market by Country
6.5 LAMEA Cancer Market by Country
6.6 LAMEA Others Market by Country
Chapter 7. LAMEA Chronic Disease Management Market by Country
7.1 Brazil Chronic Disease Management Market
7.1.1 Brazil Chronic Disease Management Market by Type
7.1.2 Brazil Chronic Disease Management Market by End User
7.1.3 Brazil Chronic Disease Management Market by Disease Type
7.2 Argentina Chronic Disease Management Market
7.2.1 Argentina Chronic Disease Management Market by Type
7.2.2 Argentina Chronic Disease Management Market by End User
7.2.3 Argentina Chronic Disease Management Market by Disease Type
7.3 UAE Chronic Disease Management Market
7.3.1 UAE Chronic Disease Management Market by Type
7.3.2 UAE Chronic Disease Management Market by End User
7.3.3 UAE Chronic Disease Management Market by Disease Type
7.4 Saudi Arabia Chronic Disease Management Market
7.4.1 Saudi Arabia Chronic Disease Management Market by Type
7.4.2 Saudi Arabia Chronic Disease Management Market by End User
7.4.3 Saudi Arabia Chronic Disease Management Market by Disease Type
7.5 South Africa Chronic Disease Management Market
7.5.1 South Africa Chronic Disease Management Market by Type
7.5.2 South Africa Chronic Disease Management Market by End User
7.5.3 South Africa Chronic Disease Management Market by Disease Type
7.6 Nigeria Chronic Disease Management Market
7.6.1 Nigeria Chronic Disease Management Market by Type
7.6.2 Nigeria Chronic Disease Management Market by End User
7.6.3 Nigeria Chronic Disease Management Market by Disease Type
7.7 Rest of LAMEA Chronic Disease Management Market
7.7.1 Rest of LAMEA Chronic Disease Management Market by Type
7.7.2 Rest of LAMEA Chronic Disease Management Market by End User
7.7.3 Rest of LAMEA Chronic Disease Management Market by Disease Type
Chapter 8. Company Profiles
8.1 Infosys Limited
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 ExlService Holdings, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.3 Health Catalyst, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.4 AllScripts Healthcare Solutions, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional & Segmental Analysis
8.4.4 Research & Development Expenses
8.5 Koninklijke Philips N.V.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.5.5.3 Acquisition and Mergers:
8.5.5.4 Approvals and Trials:
8.6 Cognizant Technology Solutions Corporation
8.6.1 Company overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Recent strategies and developments:
8.6.4.1 Partnerships, Collaborations, and Agreements:
8.6.5 SWOT Analysis
8.7 Casenet, LLC (Zyter, Inc.)
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Product Launches and Product Expansions:
8.8 Cedar Gate Technologies
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Acquisition and Mergers:
8.9 Clinical Excellence, Inc.
8.9.1 Company Overview
8.10. Altruista Health, Inc. (HealthEdge Software, Inc.)
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Acquisition and Mergers:
Unique Offerings 